Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NUKK | Common Stock, $0.0001 par value per share | Purchase | +11.1M | +42.8% | 37.1M | Aug 30, 2021 | Direct | F1 | ||
transaction | NUKK | Common Stock, $0.0001 par value per share | Purchase | +37.1K | +0.14% | 26M | May 24, 2021 | Direct | F1 |
Id | Content |
---|---|
F1 | On May 24, 2021, Nukkleus Inc. (the "Company") and the shareholders of Match Financial Limited (the "Match Shareholders"), a private limited company formed in England and Wales ("Match"), entered into a Purchase and Sale Agreement (the "Match Agreement"), pursuant to which the Company, on May 28, 2021, acquired 1,152 ordinary shares of Match representing 70% of the issued and outstanding ordinary shares of Match in consideration of 70,000,000 shares of common stock of the Company (the "Initial Transaction") and issued an option to acquire the balance of Match's outstanding ordinary shares in consideration of 100,000 shares of common stock of the Company. On August 30, 2021, the Company exercised its option pursuant to which it acquired from the Match Shareholders the balance of 493 ordinary shares of Match representing 30% of the issued and outstanding ordinary shares of Match for an additional 30,000,000 shares of common stock of the Company. |